| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > Exhibits |
|
Main Subject - Exhibits
Do you wonder what enthralls an audience in a trade show? It’s not the huge crowd of people aroun According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d or the excitement in the air – it is the powerful display of products with all their sleek plac ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ments, banners, and graphics. Exhibits, a shortened form for exhibition, seek to highlight the qu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lities of new products or services before a focused audience. Exhibitions can be of different ty here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe pes. They can be art exhibitions, computer expositions, film exhibitions or industrial exhibition d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro . Exhibitions are powerful events that provide an opportunity to witness the best a company or se ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc vice provider has to offer. Exhibitions are also known as ‘expos’ in modern parlance. Exhibits a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi re powerful marketing agents that seek to bridge the gap between the buyer and the seller. In art nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically exhibits, for instance, artists display a wide array of their work before a focused audience. The and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ audience in turn generates interest by word of mouth, and consequently leads to sales of the arti ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t’s work. Exhibits are also displayed through specialized ‘exhibit booths’ in trade fairs, book ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a fairs or industrial fairs. These exhibit booths seek to bring about a direct impact on the sales dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod urve. Exhibit displays serve as a window to the external buyers, and enable them to analyze and c cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin mpare it with other products before reaching a buying decision. Modern exhibits can come in seve tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ral forms. Apart from the physical exhibits, individuals, companies and service providers today u t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e online exhibits to garner popularity and wider acceptance. Online exhibits have several advanta ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust es over physical exhibits. Online exhibits can be made in the form of sleek websites and informat y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ion portals at the fraction of the cost incurred in creating and displaying physical exhibits. Ho . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ever, in spite of such easy global reach and acceptance, physical exhibits in exhibitions and tra elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e fairs still remain a better choice. After all, it’s all too difficult to get a focused audience tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Steps to Success In Life, Business, The Universe And Everything
|